These features make them suitable for elderly patients, those with impaired renal function, and individuals intolerant to other glucose-lowering agents
The current compounding review applies to its individual compounds rather than GLOW as a finished formulation
A phase I-IIa clinical trial in combination with carboplatin and paclitaxel investigated the effect of canfosfamide in advanced non-small cell lung cancer 114
We prescribe IV therapy solutions based on our patients specific needs, such as chronic fatigue, brain fog, vitamin deficiencies, and dehydration, allowing for coverage under many insurance plans
Porcellato, E., Gonzlez-Snchez, J